Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/ecco-jcc/jjy134 | DOI Listing |
Inflamm Bowel Dis
October 2024
Department of Gastroenterology, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.
Inflamm Bowel Dis
October 2024
Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Front Oncol
July 2024
Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States.
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, with relapse being a major obstacle to successful treatment. Our understanding of the mechanisms driving chemotherapy resistance and ultimately relapse in leukemia remains incomplete. Herein, we investigate the impact of the tumor microenvironment on leukemia cell drug responses using human plasma-like media (HPLM), designed to mimic physiological conditions more accurately .
View Article and Find Full Text PDFInflamm Bowel Dis
December 2024
Department of Gastroenterology, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.
Thiopurines remain an important option in the treatment of IBD. However, the unpredictable and sometimes serious side effects and intolerance remain a major challenge. Pretreatment of extended genetic panel analysis, identification of novel variants, and monitoring of intermediate metabolites will help improve the overall outcome and reduce the toxicity.
View Article and Find Full Text PDFInflamm Bowel Dis
October 2024
Human Genetics and Genomic Medicine, University of Southampton, Southampton, United Kingdom.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!